FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of organic chemistry, namely to method of obtaining compounds of formula , where each of R1, R2, R3 and R4, which can be similar or different, represents hydrogen atom or lower alkyl group, including removal of protective group (R5) from formula compound, where R5 represents benzyl group, which can be substituted by reduction in presence of reducing agent of catalytic hydrogenation. Invention also relates to intermediate compound of formula (2) or , as well as to method of its obtaining.
EFFECT: industrially efficient, simple and effective method of obtaining basic intermediate product for production of therapeutic anti-arrhythmia means is developed.
6 cl, 44 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF CONDENSED POLYCYCLIC HETEROCYCLIC COMPOUNDS AND METHOD OF THEIR SYNTHESIS | 1996 |
|
RU2167877C2 |
QUINOLONE COMPOUND AND PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2544530C2 |
NOVEL HETEROCYCLIC COMPOUNDS AND USE THEREOF IN MEDICINE AND COSMETICS | 2015 |
|
RU2712971C2 |
DIAZABICYCLOALKENE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2126008C1 |
PENTACYCLIC HETEROCYCLIC COMPOUND | 2020 |
|
RU2815382C2 |
DERIVATIVES OF PHENANTHRIDINIUM SHOWING ANTITUMOR ACTIVITY, METHOD OF INHIBITION OF CANCER CELLS GROWTH | 1997 |
|
RU2183626C2 |
GAMMA-DIKETONES AS WNT/BETA-CATENIN SIGNALING PATHWAY ACTIVATORS | 2014 |
|
RU2680716C2 |
BENZAZEPIN DERIVATIVES APPLICABLE AS VASOPRESSIN ANTAGONISTS | 2008 |
|
RU2471784C2 |
CONDENSED HETEROCYCLIC DERIVATIVE, THERAPEUTIC COMPOSITION WHICH CONTAINS IT AND ITS APPLICATION IN MEDICINE | 2006 |
|
RU2418803C2 |
CYCLOALKANE DERIVATIVE | 2013 |
|
RU2635354C2 |
Authors
Dates
2015-06-20—Published
2010-08-20—Filed